These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6451183)

  • 1. Changes in pulmonary structure and function induced by monocrotaline intoxication.
    Ghodsi F; Will JA
    Am J Physiol; 1981 Feb; 240(2):H149-55. PubMed ID: 6451183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary vasculature in monocrotaline-induced hypertensive rats on magnesium therapy.
    Mathew R; Gloster ES; Altura BT; Altura BM
    Microcirc Endothelium Lymphatics; 1990; 6(4-5):267-83. PubMed ID: 2149161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin converting enzyme activity and evolution of pulmonary vascular disease in rats with monocrotaline pulmonary hypertension.
    Kay JM; Keane PM; Suyama KL; Gauthier D
    Thorax; 1982 Feb; 37(2):88-96. PubMed ID: 6281933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right ventricular performance after monocrotaline-induced pulmonary hypertension.
    Werchan PM; Summer WR; Gerdes AM; McDonough KH
    Am J Physiol; 1989 May; 256(5 Pt 2):H1328-36. PubMed ID: 2524170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SC-39026, a serine elastase inhibitor, prevents muscularization of peripheral arteries, suggesting a mechanism of monocrotaline-induced pulmonary hypertension in rats.
    Ilkiw R; Todorovich-Hunter L; Maruyama K; Shin J; Rabinovitch M
    Circ Res; 1989 Apr; 64(4):814-25. PubMed ID: 2495195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supplemental oxygen reduces right ventricular hypertrophy in monocrotaline-injected rats.
    Hill NS; Jederlinic P; Gagnon J
    J Appl Physiol (1985); 1989 Apr; 66(4):1642-8. PubMed ID: 2525121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnesium aspartate hydrochloride attenuates monocrotaline-induced pulmonary artery hypertension in rats.
    Mathew R; Gloster ES; Altura BT; Altura BM
    Clin Sci (Lond); 1988 Dec; 75(6):661-7. PubMed ID: 2974771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Crotalaria pulmonary hypertension: hemodynamic and structural study.
    Meyrick B; Gamble W; Reid L
    Am J Physiol; 1980 Nov; 239(5):H692-702. PubMed ID: 6449154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin converting enzyme inhibitor protects development of right ventricular overload and medial thickening of pulmonary arteries in rats with monocrotaline-induced pulmonary hypertension.
    Takahashi T; Kanda T; Inoue M; Sumino H; Kobayashi I; Iwamoto A; Nagai R
    Life Sci; 1998; 63(10):PL137-43. PubMed ID: 9734710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure to show decrease in small pulmonary blood vessels in rats with experimental pulmonary hypertension.
    Kay JM; Suyama KL; Keane PM
    Thorax; 1982 Dec; 37(12):927-30. PubMed ID: 6820578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in main pulmonary artery of rats with monocrotaline-induced pulmonary hypertension.
    Guzowski DE; Salgado ED
    Arch Pathol Lab Med; 1987 Aug; 111(8):741-5. PubMed ID: 3115224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-response relationship in intoxication by the pyrrolizidine alkaloid monocrotaline.
    Shubat PJ; Hubbard AK; Huxtable RJ
    J Toxicol Environ Health; 1989; 28(4):445-60. PubMed ID: 2531804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary hypertension induced in rats by monocrotaline and chronic hypoxia is reduced by p-chlorophenylalanine.
    Kay JM; Keane PM; Suyama KL
    Respiration; 1985; 47(1):48-56. PubMed ID: 3156395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of verapamil on monocrotaline-induced pulmonary artery hypertension and endothelial cell dysfunction in rats.
    Mathew R; Guzowski DE; Gloster ES
    Exp Lung Res; 1990; 16(6):627-44. PubMed ID: 1964410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of hypobaric hypoxia in infancy on the subsequent development of vasoconstrictive pulmonary vascular disease in the Wistar albino rat.
    Caslin A; Heath D; Smith P
    J Pathol; 1991 Feb; 163(2):133-41. PubMed ID: 1901909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered artery mechanics and structure in monocrotaline pulmonary hypertension.
    Langleben D; Szarek JL; Coflesky JT; Jones RC; Reid LM; Evans JN
    J Appl Physiol (1985); 1988 Nov; 65(5):2326-31. PubMed ID: 3145283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of methylprednisolone on monocrotaline-induced pulmonary vascular disease and right ventricular hypertrophy.
    Langleben D; Reid LM
    Lab Invest; 1985 Mar; 52(3):298-303. PubMed ID: 3156262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical sympathectomy and serotonin inhibition reduce monocrotaline-induced right ventricular hypertrophy in rats.
    Tucker A; Bryant SE; Frost HH; Migally N
    Can J Physiol Pharmacol; 1983 Apr; 61(4):356-62. PubMed ID: 6222785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung vessel leak precedes right ventricular hypertrophy in monocrotaline-treated rats.
    Sugita T; Hyers TM; Dauber IM; Wagner WW; McMurtry IF; Reeves JT
    J Appl Physiol Respir Environ Exerc Physiol; 1983 Feb; 54(2):371-4. PubMed ID: 6219974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole.
    Reindel JF; Ganey PE; Wagner JG; Slocombe RF; Roth RA
    Toxicol Appl Pharmacol; 1990 Nov; 106(2):179-200. PubMed ID: 2256110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.